Cargando…
MicroRNA-200a-3p and GATA6 are abnormally expressed in patients with non-small cell lung cancer and exhibit high clinical diagnostic efficacy
Lung cancer is one of the main threats to human health. Survival of patients with lung cancer depends on timely detection and diagnosis. Among the genetic irregularities that control cancer development and progression, there are microRNAs (miRNAs/miRs). The present study aimed to investigate the exp...
Autores principales: | Yu, Jie, He, Xinyun, Fang, Chunju, Wu, Haixia, Hu, Lei, Xue, Yingbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908458/ https://www.ncbi.nlm.nih.gov/pubmed/35317445 http://dx.doi.org/10.3892/etm.2022.11210 |
Ejemplares similares
-
Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma
por: Dhayat, Sameer A., et al.
Publicado: (2015) -
Characterization of the developing small intestine in the absence of either GATA4 or GATA6
por: Walker, Emily M, et al.
Publicado: (2014) -
LncRNA GATA6-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer via Repressing microRNA-543 to Up-Regulating RKIP
por: Gong, Zixuan, et al.
Publicado: (2020) -
The MicroRNA-200 Family Is Upregulated in Endometrial Carcinoma
por: Snowdon, Jaime, et al.
Publicado: (2011) -
Emerging Role of MicroRNA-200 Family in Dentistry
por: Hsieh, Pei-Ling, et al.
Publicado: (2021)